【OviBees Ventures×Japan Society】From Lab To Market, Commercializing University Technologies, U.S. and Japan

*Online Event

Join us for an exciting online event where we will dive into the world of biotechnology and explore practical strategies to bring university technologies from lab to market. We will introduce best practices and examples from three of the best universities in the world, MIT, Stanford and UC Irvine. The virtual broadcast will also introduce how other prestigious institutions such as the National Science Foundation in the U.S. work to support technology commercialization through grants like SBIR.

During this event, you’ll learn about the latest trends in the biotech industry, discover effective commercialization strategies and gain valuable networking opportunities with like-minded professionals. Our expert speakers will share their success stories, challenges, and strategies for intellectual property research, technologies mapping, entrepreneurship ecosystem support, helping you navigate the world of attracting technology commercialization in the biotech sector from the U.S. and Japan.

This event is part of BioJent, a one-year entrepreneurship program, supported by the U.S Embassy Tokyo and U.S. Consulate Fukuoka and implemented by The Japan Society of Northern California and OviBees Ventures. Details at the links below.

Register now to secure your spot and join us for an event that promises to inspire, educate, and empower!

The Zoom link will the shared with the registered attendees three days before the event.

大学発のバイオテクノロジーの技術の新規市場参入。このテーマを中心に、マサチューセッツ工科大学 、スタンフォード大学、カリフォルニア大学アーバイン校という世界最高の3大学の事例をご紹介します (英語プログラム）

Our Amazing Speakers

Joe Hadzima – President IP Vision, Senior Lecturer MIT Sloan School of Management 

Joseph Hadzima is a Senior Lecturer in the Martin Trust Center for MIT Entrepreneurship. Hadzima works in the areas of entrepreneurship, startup phase companies, business plans, venture capital, corporate governance, and intellectual property strategy. He has been involved in the founding of more than 100 companies as a founder, investor, director, legal counsel, or employee, and has advised entrepreneurs, high-growth businesses, and venture capitalists.

_

Rieko Yajima – Director Drug Discovery and Innovations, Stanford University, Spark Program.

Ph.D. life scientist with 8 years of experience in science policy and 2 years in human-centered design research. Focus on transdisciplinary and team science collaboration strategies and development. Currently with the Center for Design Research at Stanford University investigating the role of design in scientific discovery and translational research, particularly in drug discovery R&D.

__

_

Errol Arkilic – Chief Innovation Officer, UC Irvine, and Exec. Director Beall Applied Innovation

Errol Arkilic, chief innovation officer at the University of California, Irvine (UCI), and executive director of Beall Applied Innovation, is a distinguished figure in academic-initiated technology commercialization. Before joining UCI in October 2021, he led M34 Capital, a venture firm specializing in academic spinouts. Arkilic is also renowned as the founder of the National Science Foundation Innovation Corps (I-Corps) program.

_

Moderator: Ovidiu Bujorean – Founder and CEO, OviBees Ventures

Ovidiu Bujorean, a MIT and Harvard alumni and scholar of the Joint Japan/World Bank Graduate Scholarship Program, the founder of OviBees Ventures, is a leader in designing and implementing platforms that encourage technology-based entrepreneurship at country and regional levels. His previous work with The GIST Network, the U.S. Department of State flagship entrepreneurship program, a global enterprise building entrepreneurial ecosystems across 135 countries, showcased his dedication to fostering entrepreneurship on a global scale.

_

In Partnership with the U.S. Embassy Tokyo and U.S. Consulate in Fukuoka

_

In Cooperation with

__
__

__

__